Brief: Race Oncology Gets Receives Governance Approval For AML EMD & MDS Trial
12/05/2022 02:55
May 12 (Reuters) - Race Oncology Ltd RAC.AX :
* RACE ONCOLOGY LTD - RACE RECEIVES GOVERNANCE APPROVAL FOR
AML
EMD & MDS TRIAL-RAC.AX
Source text for Eikon: ID:nASX7nWFgG
Further company coverage: RAC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220